Gemtuzumab Intravenous and NovoLog PenFill

• Generic Name: gemtuzumab
• Dosage Forms: n.a.
• Other Brand Names: Mylotarg

Gemtuzumab injection is used alone or together with other medicines (eg, cytarabine, daunorubicin) to treat newly-diagnosed CD33-positive acute myeloid leukemia (AML) in adults. It is also used to treat CD33-positive AML that has come back or after other medicines did not work well, in adults and children 2 years of age and older.

Gemtuzumab is an antineoplastic (cancer) medicine. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal cells may also be affected by gemtuzumab, other side effects can occur. Before you begin treatment, talk to your doctor about the benefits of gemtuzumab as well as the possible risks of using it.

Gemtuzumab is to be given only by or under the direct supervision of your doctor.

• Generic Name: insulin aspart
• Dosage Forms: n.a.
• Other Brand Names: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch

Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. NovoLog PenFill is a fast-acting insulin that starts to work about 15 minutes after injection, peaks in about 1 hour, and keeps working for 2 to 4 hours.

NovoLog PenFill is used to improve blood sugar control in adults and children with diabetes mellitus. NovoLog PenFill is sometimes used together with a long-acting or intermediate-acting insulin.

NovoLog PenFill may also be used for purposes not listed in this medication guide.